Claes Blanche

Claes Blanche possesses extensive experience in the Life Science and MedTech industries, currently serving as a Board Member and Commercial Advisor at Nordic Biomarker since April 2019. Claes founded BLANCHE Life Science Advisors in March 2018, focusing on management consultation and advisory services. Previous roles include Board Member at Capitainer AB and Glycorex Transplantation AB, Advisor in Global Sales & Marketing at ObsteCare AB, and Commercial Advisor at HiloProbe. Claes served as President of Boule Diagnostics AB from January 2012 to September 2018 and held managerial positions at Sorin Group and Guidant/Boston Scientific. Educational background includes an MSc in Biochemistry from KTH Royal Institute of Technology and a degree in Finance Management from the Stockholm School of Economics.